Molecular Neuropharmacology (C7128)
Molecular Neuropharmacology
Module C7128
Module details for 2025/26.
15 credits
FHEQ Level 6
Module Outline
A molecular understanding of human health and disease and the mode of action of drugs is crucial for the development of new drugs with improved potency and reduced side effects. It also underpins the development of personalized medicine, which is about giving the right treatment to the right people at the right time and is a move away from ‘one size fits all’ approach to the treatment of patients with a particular condition. This module will inform you of all aspects of the drug discovery process and discuss the challenges of improving drug treatment of example diseases with an unmet medical need.
Module learning outcomes
Demonstrate an understanding of the principles of drug action (i.e., the concepts of agonism, antagonism, inverse agonism and allosteric modulation)
Understand the role of basic science in elucidating disease mechanisms and in the characterization and validation of drug targets.
Understand the drug discovery process, from the earliest stages of preclinical studies through clinical trials to FDA/MHRA approval.
Understand how drug discovery has progressed for specific diseases and appreciate the challenges that need to be overcome to improve treatment of diseases with an unmet medical need.
| Type | Timing | Weighting |
|---|---|---|
| Coursework | 30.00% | |
| Coursework components. Weighted as shown below. | ||
| Test | T2 Week 7 (45 minutes) | 50.00% |
| Test | T2 Week 11 (45 minutes) | 50.00% |
| Computer Based Exam | Semester 2 Assessment | 70.00% |
Timing
Submission deadlines may vary for different types of assignment/groups of students.
Weighting
Coursework components (if listed) total 100% of the overall coursework weighting value.
| Term | Method | Duration | Week pattern |
|---|---|---|---|
| Spring Semester | Lecture | 2 hours | 11111111111 |
How to read the week pattern
The numbers indicate the weeks of the term and how many events take place each week.
Dr Ruth Murrell-Lagnado
Convenor, Assess convenor
/profiles/24978
Please note that the University will use all reasonable endeavours to deliver courses and modules in accordance with the descriptions set out here. However, the University keeps its courses and modules under review with the aim of enhancing quality. Some changes may therefore be made to the form or content of courses or modules shown as part of the normal process of curriculum management.
The University reserves the right to make changes to the contents or methods of delivery of, or to discontinue, merge or combine modules, if such action is reasonably considered necessary by the University. If there are not sufficient student numbers to make a module viable, the University reserves the right to cancel such a module. If the University withdraws or discontinues a module, it will use its reasonable endeavours to provide a suitable alternative module.